Mediolanum International Funds Ltd Decreases Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mediolanum International Funds Ltd lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 30.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 29,250 shares of the medical equipment provider’s stock after selling 12,577 shares during the quarter. Mediolanum International Funds Ltd’s holdings in Intuitive Surgical were worth $15,376,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Quarry LP lifted its stake in Intuitive Surgical by 134.7% during the second quarter. Quarry LP now owns 115 shares of the medical equipment provider’s stock worth $51,000 after purchasing an additional 66 shares during the last quarter. New Century Financial Group LLC acquired a new position in shares of Intuitive Surgical in the 2nd quarter valued at $251,000. Dana Investment Advisors Inc. grew its position in shares of Intuitive Surgical by 5.0% in the 2nd quarter. Dana Investment Advisors Inc. now owns 1,904 shares of the medical equipment provider’s stock valued at $847,000 after buying an additional 90 shares during the last quarter. Sanctuary Advisors LLC acquired a new stake in Intuitive Surgical during the 2nd quarter worth $22,957,000. Finally, Healthcare of Ontario Pension Plan Trust Fund boosted its stake in Intuitive Surgical by 617.1% in the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after acquiring an additional 76,649 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the sale, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. The trade was a 3.45 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 28,843 shares of company stock worth $15,357,560 over the last ninety days. 0.90% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research firms have recently commented on ISRG. Wells Fargo & Company lifted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Robert W. Baird boosted their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Citigroup raised their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Stifel Nicolaus upped their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. Finally, Piper Sandler reissued an “overweight” rating and set a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Stock Up 1.3 %

NASDAQ ISRG opened at $580.18 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The business has a fifty day moving average of $549.32 and a 200-day moving average of $507.50. The stock has a market cap of $206.65 billion, a price-to-earnings ratio of 90.51, a price-to-earnings-growth ratio of 5.52 and a beta of 1.39.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.